Tiziana Life Sciences PLC TLSA
$ 0.99
6.51%
Annual report 2023
added 12-07-2024
Tiziana Life Sciences PLC Balance Sheet 2011-2024 | TLSA
Annual Balance Sheet Tiziana Life Sciences PLC
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | - | - | -3.94 M | 186 K | -4.48 M | -8.69 M | -2.06 M | 169 K | -4 K | -33 K | ||
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
138 K | 122 K | - | 265 K | 279 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 290 K | 411 K | - | - | - | - | - | - | - | - |
Total Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
6.65 M | 6.91 M | 7.55 M | 8.27 M | 7.89 M | 6.4 M | 3.51 M | 1.74 M | 746 K | 683 K | 272 K | 136 K | 100 K |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | - | - | -84.6 M | -43.1 M | -39.9 M | -29.8 M | 11 M | -12.2 M | -3.59 M | -21.4 M | -21.1 M | -20.5 M |
Total Assets |
12.2 M | 26.5 M | 48.8 M | 70.7 M | 2.38 M | 6.92 M | 1.83 M | 5.05 M | 9.25 M | 2.46 M | 126 K | 96 K | 625 K |
Cash and Cash Equivalents |
1.18 M | 18.1 M | 42.2 M | 65.8 M | 200 K | 5.3 M | 64 K | 5.8 M | - | - | - | - | - |
Book Value |
5.54 M | 19.6 M | 41.3 M | 62.4 M | -5.51 M | 519 K | -1.68 M | 3.31 M | 8.5 M | 1.78 M | -146 K | -40 K | 525 K |
Total Shareholders Equity |
- | - | - | 62.4 M | -5.51 M | 519 K | -2.28 M | 4.09 M | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Tiziana Life Sciences PLC
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | - | - | - | - | 290 K | - | - | - | 541 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | - | 7.55 M | - | - | - | 8.27 M | - | - | - | 7.89 M | - | - | - | 6.4 M | - | - | - | 4.75 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | - | - | - | -108 M | - | - | - | -84.6 M | - | - | - | -60 M | - | - | - | -50.7 M | - | - | - | -42.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
- | - | - | - | 48.8 M | - | - | - | 70.7 M | - | - | - | 2.38 M | - | - | - | 6.92 M | - | - | - | 2.47 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
- | - | - | - | 42.2 M | - | - | - | 65.8 M | - | - | - | 200 K | - | - | - | 5.3 M | - | - | - | 64 K | - | - | - | 5.8 M | - | - | - | 13.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
- | - | - | - | 41.3 M | - | - | - | 62.4 M | - | - | - | -5.51 M | - | - | - | 519 K | - | - | - | -2.28 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
- | - | - | - | 41.3 M | - | - | - | 62.4 M | - | - | - | 69.6 M | - | - | - | 75.8 M | - | - | - | -2.28 M | - | - | - | 4.09 M | - | - | - | 12.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency